Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "95.32",
    "chg": 2.63,
    "chgp": "2.84%",
    "dir": 1,
    "prev_price": "92.69",
    "mcapval": "151.76 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Sep 08, 11:45 AM",
    "curr_time": "12:04 PM",
    "last_traded_at": "Sep 08, 11:45 AM IST",
    "bse_nse_vol": "94.35 k",
    "exc_status": "Active",
    "traded_date": "Sep 08, 2026",
    "traded_date_str": "2026 09 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd Upgraded to Hold as Technicals Improve and Valuation Attractiveness Increases",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-upgraded-to-hold-as-technicals-improve-and-valuation-attractiveness-increases-4185914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_mojoScore_4185914.png",
        "date": "2026-09-08 08:26:51",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a notable improvement in the company’s technical indicators and valuation metrics, despite flat financial performance in the recent quarter. Investors are advised to consider the nuanced developments across quality, valuation, financial trends, and technicals before making decisions."
      },
      {
        "title": "Bal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-sell-by-marketsmojo-4177584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BalPharmaLtd_mojoScore_4177584.png",
        "date": "2026-09-01 10:11:23",
        "description": "Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4159053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_mojoScore_4159053.png",
        "date": "2026-08-18 08:26:31",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Aug 2026. This decision follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite a very attractive valuation, concerns over flat financial performance, weak long-term fundamentals, and mixed technical signals have weighed heavily on the stock’s outlook."
      },
      {
        "title": "Bal Pharma Ltd Falls 3.17%: Valuation Shift and Technical Upgrade Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-317-valuation-shift-and-technical-upgrade-shape-the-week-4155898",
        "imagepath": "",
        "date": "2026-08-15 17:00:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>10 Aug:</strong> Stock opens at Rs.90.93, up 1.73% on positive momentum</p>\n                    <p><strong>12 Aug:</strong> MarketsMOJO upgrades Bal Pharma Ltd to Hold on technical and valuation improvements</p>\n                    <p><strong>14 Aug:</strong> Valuation shifts to very attractive despite share price dip to Rs.86.55</p>\n                    <p><strong>14 Aug:</strong> Week closes at Rs.86.55, down 3.17% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.89.38</div>\n                 ..."
      },
      {
        "title": "Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-shifts-to-very-attractive-amid-mixed-market-returns-4152650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_valuationdot_4152650.png",
        "date": "2026-08-14 08:01:02",
        "description": "Bal Pharma Ltd has seen a marked improvement in its valuation parameters, shifting from an attractive to a very attractive rating, despite a recent dip in share price and ongoing sector headwinds. This development comes as the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bal Pharma Ltd Upgraded to Hold by MarketsMOJO on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-upgraded-to-hold-by-marketsmojo-on-technical-and-valuation-improvements-4151202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_mojoScore_4151202.png",
        "date": "2026-08-13 08:13:05",
        "description": "Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite ongoing challenges in its financial trend and long-term fundamentals. The upgrade, effective from 12 August 2026, is driven primarily by a bullish shift in technicals and an attractive valuation relative to peers, while the company’s quality and financial trend parameters remain subdued."
      },
      {
        "title": "Bal Pharma Ltd Downgraded to Sell Amid Weak Fundamentals and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-downgraded-to-sell-amid-weak-fundamentals-and-mixed-technical-signals-4141166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_mojoScore_4141166.png",
        "date": "2026-08-07 08:17:20",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 August 2026. This change reflects a combination of deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, despite some attractive valuation metrics. The company’s stock price has also underperformed key benchmarks, signalling caution for investors."
      },
      {
        "title": "When is the next results date for Bal Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bal-pharma-ltd-4140500",
        "imagepath": "",
        "date": "2026-08-06 23:18:52",
        "description": "The next results date for Bal Pharma Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Bal Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-hold-by-marketsmojo-4139550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_mojoScore_4139550.png",
        "date": "2026-08-06 10:11:57",
        "description": "Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 165,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "details": "Bal Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Bal Pharma Limited Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Clarification - Financial Results",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Bal Pharma Limited has informed the Exchange regarding 'News Paper Publication's of Unaudited financial results for the quarter and half year ended 30/09/2019.'.",
      "source": "NSE",
      "caption": "Bal Pharma Limited - Updates",
      "datetime": "18-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 17 Sep 26",
          "dt": "2026-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd Upgraded to Hold as Technicals Improve and Valuation Attractiveness Increases

2026-09-08 08:26:51

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a notable improvement in the company’s technical indicators and valuation metrics, despite flat financial performance in the recent quarter. Investors are advised to consider the nuanced developments across quality, valuation, financial trends, and technicals before making decisions.

Read full news article

Bal Pharma Ltd is Rated Sell by MarketsMOJO

2026-09-01 10:11:23

Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-08-18 08:26:31

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Aug 2026. This decision follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite a very attractive valuation, concerns over flat financial performance, weak long-term fundamentals, and mixed technical signals have weighed heavily on the stock’s outlook.

Read full news article

Bal Pharma Ltd Falls 3.17%: Valuation Shift and Technical Upgrade Shape the Week

2026-08-15 17:00:53

Key Events This Week

10 Aug: Stock opens at Rs.90.93, up 1.73% on positive momentum

12 Aug: MarketsMOJO upgrades Bal Pharma Ltd to Hold on technical and valuation improvements

14 Aug: Valuation shifts to very attractive despite share price dip to Rs.86.55

14 Aug: Week closes at Rs.86.55, down 3.17% for the week

Week Open

Rs.89.38

...

Read full news article

Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Mixed Market Returns

2026-08-14 08:01:02

Bal Pharma Ltd has seen a marked improvement in its valuation parameters, shifting from an attractive to a very attractive rating, despite a recent dip in share price and ongoing sector headwinds. This development comes as the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within the Pharmaceuticals & Biotechnology sector.

Read full news article

Bal Pharma Ltd Upgraded to Hold by MarketsMOJO on Technical and Valuation Improvements

2026-08-13 08:13:05

Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite ongoing challenges in its financial trend and long-term fundamentals. The upgrade, effective from 12 August 2026, is driven primarily by a bullish shift in technicals and an attractive valuation relative to peers, while the company’s quality and financial trend parameters remain subdued.

Read full news article

Bal Pharma Ltd Downgraded to Sell Amid Weak Fundamentals and Mixed Technical Signals

2026-08-07 08:17:20

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 August 2026. This change reflects a combination of deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, despite some attractive valuation metrics. The company’s stock price has also underperformed key benchmarks, signalling caution for investors.

Read full news article

When is the next results date for Bal Pharma Ltd?

2026-08-06 23:18:52

The next results date for Bal Pharma Ltd is scheduled for 12 August 2026....

Read full news article

Bal Pharma Ltd is Rated Hold by MarketsMOJO

2026-08-06 10:11:57

Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News